 | • レポートコード：MRC23Q36446 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のペット用医薬品市場について調査・分析し、世界のペット用医薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（注射、飲用）、用途別セグメント分析（農場、動物病院、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Zoetis、Boehringer Ingelheim、Merck Animal Health、Elanco Animal Health、Bayer Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Parnellなどが含まれています。世界のペット用医薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ペット用医薬品市場規模を推定する際に考慮しました。本レポートは、ペット用医薬品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ペット用医薬品に関するビジネス上の意思決定に役立てることを目的としています。 ・ペット用医薬品市場の概要 - ペット用医薬品のタイプ別セグメント - 世界のペット用医薬品市場規模：タイプ別分析（注射、飲用） - ペット用医薬品の用途別セグメント - 世界のペット用医薬品市場規模：用途別分析（農場、動物病院、その他） - 世界のペット用医薬品市場規模予測（2018年-2029年） ・ペット用医薬品市場の成長トレンド - ペット用医薬品の地域別市場規模（2018年-2029年） - ペット用医薬品市場ダイナミクス - ペット用医薬品の業界動向 - ペット用医薬品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：注射、飲用 - 世界のペット用医薬品のタイプ別市場規模（2018年-2023年） - 世界のペット用医薬品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：農場、動物病院、その他 - 世界のペット用医薬品の用途別市場規模（2018年-2023年） - 世界のペット用医薬品の用途別市場規模（2024年-2029年） ・ペット用医薬品の地域別市場規模 - 北米のペット用医薬品市場規模（2018年-2029年） - アメリカのペット用医薬品市場規模（2018年-2029年） - ヨーロッパのペット用医薬品市場規模（2018年-2029年） - アジア太平洋のペット用医薬品市場規模（2018年-2029年） - 中国のペット用医薬品市場規模（2018年-2029年） - 日本のペット用医薬品市場規模（2018年-2029年） - 韓国のペット用医薬品市場規模（2018年-2029年） - インドのペット用医薬品市場規模（2018年-2029年） - オーストラリアのペット用医薬品市場規模（2018年-2029年） - 中南米のペット用医薬品市場規模（2018年-2029年） - 中東・アフリカのペット用医薬品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Zoetis、Boehringer Ingelheim、Merck Animal Health、Elanco Animal Health、Bayer Animal Health、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Meiji、Ouro Fino Saude、Parnell ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Veterinary Drugs for Companion Animals market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Veterinary Drugs for Companion Animals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Veterinary Drugs for Companion Animals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Veterinary Drugs for Companion Animals in Farm is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Veterinary Drugs for Companion Animals include Zoetis, Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Virbac, Dechra Veterinary Products, Ceva and Vetoquinol, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Drugs for Companion Animals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drugs for Companion Animals.
The Veterinary Drugs for Companion Animals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Drugs for Companion Animals market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drugs for Companion Animals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Injection
Taking Class
Segment by Application
Farm
Veterinary Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Drugs for Companion Animals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Drugs for Companion Animals Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Injection
1.2.3 Taking Class
1.3 Market by Application
1.3.1 Global Veterinary Drugs for Companion Animals Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Farm
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Drugs for Companion Animals Market Perspective (2018-2029)
2.2 Veterinary Drugs for Companion Animals Growth Trends by Region
2.2.1 Global Veterinary Drugs for Companion Animals Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Veterinary Drugs for Companion Animals Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Drugs for Companion Animals Forecasted Market Size by Region (2024-2029)
2.3 Veterinary Drugs for Companion Animals Market Dynamics
2.3.1 Veterinary Drugs for Companion Animals Industry Trends
2.3.2 Veterinary Drugs for Companion Animals Market Drivers
2.3.3 Veterinary Drugs for Companion Animals Market Challenges
2.3.4 Veterinary Drugs for Companion Animals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Drugs for Companion Animals Players by Revenue
3.1.1 Global Top Veterinary Drugs for Companion Animals Players by Revenue (2018-2023)
3.1.2 Global Veterinary Drugs for Companion Animals Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Drugs for Companion Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Drugs for Companion Animals Revenue
3.4 Global Veterinary Drugs for Companion Animals Market Concentration Ratio
3.4.1 Global Veterinary Drugs for Companion Animals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Drugs for Companion Animals Revenue in 2022
3.5 Veterinary Drugs for Companion Animals Key Players Head office and Area Served
3.6 Key Players Veterinary Drugs for Companion Animals Product Solution and Service
3.7 Date of Enter into Veterinary Drugs for Companion Animals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Drugs for Companion Animals Breakdown Data by Type
4.1 Global Veterinary Drugs for Companion Animals Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Drugs for Companion Animals Forecasted Market Size by Type (2024-2029)
5 Veterinary Drugs for Companion Animals Breakdown Data by Application
5.1 Global Veterinary Drugs for Companion Animals Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Drugs for Companion Animals Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Veterinary Drugs for Companion Animals Market Size (2018-2029)
6.2 North America Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Veterinary Drugs for Companion Animals Market Size by Country (2018-2023)
6.4 North America Veterinary Drugs for Companion Animals Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Drugs for Companion Animals Market Size (2018-2029)
7.2 Europe Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Veterinary Drugs for Companion Animals Market Size by Country (2018-2023)
7.4 Europe Veterinary Drugs for Companion Animals Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Drugs for Companion Animals Market Size (2018-2029)
8.2 Asia-Pacific Veterinary Drugs for Companion Animals Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2018-2023)
8.4 Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Drugs for Companion Animals Market Size (2018-2029)
9.2 Latin America Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Veterinary Drugs for Companion Animals Market Size by Country (2018-2023)
9.4 Latin America Veterinary Drugs for Companion Animals Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Drugs for Companion Animals Market Size (2018-2029)
10.2 Middle East & Africa Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2018-2023)
10.4 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Veterinary Drugs for Companion Animals Introduction
11.1.4 Zoetis Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Veterinary Drugs for Companion Animals Introduction
11.2.4 Boehringer Ingelheim Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Veterinary Drugs for Companion Animals Introduction
11.3.4 Merck Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Detail
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Veterinary Drugs for Companion Animals Introduction
11.4.4 Elanco Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Detail
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Veterinary Drugs for Companion Animals Introduction
11.5.4 Bayer Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Detail
11.6.2 Virbac Business Overview
11.6.3 Virbac Veterinary Drugs for Companion Animals Introduction
11.6.4 Virbac Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Detail
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Veterinary Drugs for Companion Animals Introduction
11.7.4 Dechra Veterinary Products Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Detail
11.8.2 Ceva Business Overview
11.8.3 Ceva Veterinary Drugs for Companion Animals Introduction
11.8.4 Ceva Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Detail
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Veterinary Drugs for Companion Animals Introduction
11.9.4 Vetoquinol Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Detail
11.10.2 Meiji Business Overview
11.10.3 Meiji Veterinary Drugs for Companion Animals Introduction
11.10.4 Meiji Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Detail
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Veterinary Drugs for Companion Animals Introduction
11.11.4 Ouro Fino Saude Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Detail
11.12.2 Parnell Business Overview
11.12.3 Parnell Veterinary Drugs for Companion Animals Introduction
11.12.4 Parnell Revenue in Veterinary Drugs for Companion Animals Business (2018-2023)
11.12.5 Parnell Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details